The Manila Times9h
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...
Mirage News3h
Third IHR Committee Meets on 2024 Mpox Surge
The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the ...